Prospective Evaluation of a New Approach to Perform an Esophageal Myotomy: the Transesophageal Submucosa Approach
Study Details
Study Description
Brief Summary
Achalasia is an esophagus motor disability characterized by a lack of relaxation of the lower esophageal sphincter (LES) to deglutition. Myotomy is the gold standard surgical technique allowing to cure this pathology. In this study, investigators are using a new endoluminal technique of myotomy, innovative and less invasive, called POEM (PerOral Endoscopic Myotomy). This technique does not require any cutaneous incision.
Mini-invasive surgery is more and more associated to endoscopy. The practice was initiated by the accession of natural orifice transluminal endoscopic surgery (NOTES). In this context, the introduction of the POEM technique seems to be an original approach and a natural evolution to a new generation of surgical endoscopy.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Peroral endoscopic myotomy
|
Procedure: Peroral endoscopic myotomy
Peroral endoscopic myotomy
|
Outcome Measures
Primary Outcome Measures
- The safety assessment will be based on the reading of all surgical intraoperative complications [6 months post surgery]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Esophagus achalasia
-
Confirmed by esophageal manometry
-
Requiring surgical care
-
No contraindication to general anesthesia
-
BMI under 40 kg/m²
-
Ability to give an informed consent
-
Candidate to elective Heller's myotomy
-
Affiliation to a social security system
-
Signed and informed consent
Exclusion Criteria:
-
Advanced esophageal dilatation (sigmoid megaesophagus)
-
Previous mediastinal or esophageal surgery
-
Contraindication to esophagogastroduodenoscopy (EGD)
-
Contraindication to general anesthesia
-
BMI above 40 kg/m²
-
Infectious esophagitis (e.g. candidiasis)
-
Psychiatric context unsuitable with an experimental protocol
-
Allergy to beta-lactam
-
Contraindication to endoscopy (esophageal stenosis, suspicion of digestive perforation, state of shock, severe anemia, cardiorespiratory failure or severe metabolic disorders)
-
Contraindication to monitored pneumoperitoneum (cardiorespiratory failure or severe metabolic disorders)
-
Inability to give an informed consent (emergency situations, misunderstanding…)
-
Patient in custody
-
Patient under guardianship
-
Pregnancy or breastfeeding
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University Hospital, Strasbourg, france | Strasbourg | France | 67000 |
Sponsors and Collaborators
- University Hospital, Strasbourg, France
Investigators
- Principal Investigator: Silvana PERRETTA, MD, University Hospital, Strasbourg, France
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 5368